For research use only. Not for therapeutic Use.
Anticancer agent 129(CAT: I040960) (also known as Compound 3a) is a quinoline derivative identified through computational methods, specifically Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA), as a potential anticancer compound. These studies predict its efficacy in inhibiting cancer cell proliferation. Further research, including in vitro and in vivo studies, is necessary to validate its anticancer activity and elucidate its mechanism of action. For research use only; not for human or clinical applications.
| Catalog Number | I040960 |
| CAS Number | 135882-37-0 |
| Synonyms | 1-benzyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-amine |
| Molecular Formula | C18H17N3 |
| Purity | ≥95% |
| IUPAC Name | 1-benzyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-amine |
| InChI | InChI=1S/C18H17N3/c19-17-14-8-4-5-9-16(14)20-18-15(17)10-11-21(18)12-13-6-2-1-3-7-13/h1-9H,10-12H2,(H2,19,20) |
| InChIKey | ZCZQCKJQIGWLFR-UHFFFAOYSA-N |
| SMILES | C1CN(C2=NC3=CC=CC=C3C(=C21)N)CC4=CC=CC=C4 |
